Form CORRESP - Correspondence:
SEC Accession No. 0001193125-25-016240
Filing Date
2025-01-30
Accepted
2025-01-30 07:04:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 14685
2 GRAPHIC g769642g24i75.jpg GRAPHIC 11592
  Complete submission text file 0001193125-25-016240.txt   31777
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)